Weill Cornell Medicine plans to use $2.7 million in funding to address the shortage of underrepresented minorities in the healthcare professions. According to the Association of American Medical Colleges, 1,410 African-American men applied to medical schools in 1978. Forty years later, that number has dropped to 1,337. Earlier this summer, Weill received a grant from the Health Resources and Services Administration in order to establish a Diversity Center of Excellence. The Center of Excellence, will function under the Cornell Center of Health Equity, which is a research initiative that analyzes health disparities and solutions to various stigmatized conditions.
Imagine running without being able to breathe. Sounds pretty terrible, right? Unfortunately, this is the reality that many horses suffer through. Seeking to solve this problem, Prof. Normand G. Ducharme, clinical sciences, has revitalized the equine industry with his work on respiratory illnesses in horses. Ducharme got involved with horse medicine when the success rate for helping race horses was low.
Popular legend claims that drinking from the fountain of youth will keep one’s body vigorous and vivacious for years to come. Prof. Sylvia Lee, molecular biology and genetics, may have discovered such an elixir in the soils of Ithaca. Her research indicates the secret of immortality may be hidden in the genome of a worm. Lee found that Caenorhabditis elegans, a common species of soil worm, has a very similar lifespan and reproductive pattern to humans, importantly sharing hallmark features of human aging. These similarities make C. elegans a premier experimental model to reveal the mysterious mechanisms of mortality in humans.
Meet Zhong Zhong and Hua Hua, two cloned macaque monkeys. Chinese scientists first unveiled these monkeys several weeks ago, marking the first time primates have been successfully cloned with the same method that created Dolly the sheep in 1996. Just as it did then, the science research community instantly raised ethical questions and concerns about human cloning. Theoretically, human cloning could be achieved in two ways. Reproductive human cloning would entail creating a living human, identical to another person previously or currently alive.
By SNEHA KABARIA
A team of Cornell chemical engineers in partnership with New England Biolabs have developed a method to efficiently produce antibodies in the cytoplasm in E. coli bacteria, leading to a new drug development platform. The research was led by co-senior author Prof. Matthew DeLisa, chemical engineering, and first author Michael-Paul Robinson ’16 grad. Robinson is part of the Cornell Sloan and Colman Fellowship Program, which supplied funding for the project. The research, which has been ongoing for approximately five years, was published in a paper entitled “Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria” in Nature Communications on Aug. 17.
In an effort to help alleviate the economic strain on customers, Wegmans Food Market Inc. has decided to make prescriptions for oral antibiotics free for its Club Shoppers. The program will run during the months when usage of such medicine peaks, from Jan. 7 to March 31.
“We realize that customers and employers are feeling the pinch of economy,” Jeanne Colleluori, Wegmans communications and media specialist. “One way to help people lead healthier lives is by relieving the economic pressure of their pharmaceutical requirements.”
Although Wegmans will not divulge the financial cost of this initiative, the company expects that its customers will save $1 million.